Neuraminidase (NA)

Neuraminidase (NA) 詳細

英語名Neuraminidase市販薬剤の数4
治験薬の数5ターゲットの別称Neuraminidase
研究&開発段階Approved
英語名Neuraminidase
ターゲットの別称Neuraminidase
市販薬剤の数4
治験薬の数5
研究&開発段階Approved

Neuraminidase (NA) 製品リスト

  • 属性

    Protein (4)Antibody (1)Kits (1)

  • 製品ライブラリ

    オンライン (6)

  • Influenza A virus (A/Croatia/10136RV/2023) & (A/District of Columbia/27/2023) (1)Mouse (1)Influenza (A/Wisconsin/67/2022) (1)Influenza A virus (A/Victoria/4897/2022) (1)Influenza A virus (Missouri/11/2025) (1)Influenza A virus (Sydney/1359/2024)& (Singapore/GP20238/2024) (1)

  • タグ

    His Tag (3)- (2)His Tag & Avi Tag (1)

  • マーカー

    Unconjugated (4)- (1)Biotin-labeled (1)

Neuraminidase (NA)バックグランド

Influenza, commonly known as 'the flu', is an infectious disease of birds and mammals caused by RNA viruses of the family Orthomyxoviridae, the influenza viruses. The virus is divided into three main types (Influenzavirus A, Influenzavirus B, and Influenzavirus C), which are distinguished by differences in two major internal proteins (hemagglutinin (HA) and neuraminidase (NA), which are the most important targets for the immune system. Hemagglutinin binds to the sialic acid-containing receptors on the surface of host cells during initial infection and at the end of an infectious cycle which makes it a great target for vaccine studies.

Neuraminidase (NA)分子の別称

NA,Neuraminidase

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
CD388CD-388; JNJ-0953; CD388Phase 3 ClinicalCidara Therapeutics IncInfluenza, Human
詳細
Peramivir Inhalation Solution (Langtian Medical Tech)Phase 2 ClinicalLangtian Medical Technology (Wuhan) Co LtdInfluenza A virus infections; Influenza B virus infection
詳細
Peramivir Inhalation Solution (广州南鑫药业)Phase 2 ClinicalGuangzhou Nanxin Pharma Co LtdArthralgia; Cough; Fatigue; Headache; Influenza A virus infections; Influenza B virus infection; Influenza, Human; Musculoskeletal Pain; Nasal Obstruction
詳細
Oseltamivir/PimodivirPhase 1 ClinicalJohnson & JohnsonInfluenza A virus infections
詳細
Oseltamivir orally disintegrating tablets(Hefei Industrial Pharma)HY-100209Phase 1 ClinicalHefei Industrial Pharmaceutical Co LtdInfluenza A virus infections; Influenza B virus infection
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Laninamivir Octanoate HydrateCS-8958; R-118958ApprovedDaiichi Sankyo Co LtdInavirJapanInfluenza B virus infection; Influenza A virus infections; Influenza, Humannull2010-09-10Asthma; Influenza A virus infections; Influenza B virus infection; Influenza, Human
詳細
ZanamivirGG-167; GR-121167; GR-121167X; 4-Guanidino-Neu5Ac2enApprovedGlaxosmithkline Plc依乐韦, RelenzaUnited StatesInfluenza, HumanGlaxosmithkline Plc1999-07-26Arthralgia; Dengue; Diabetes Mellitus, Type 2; Influenza, Human; Orthomyxoviridae Infections
詳細
Oseltamivir PhosphateRo-64-0796; RO-640796; GS-4104; EN-241104; RO-640796/002; GS-4104/002; GS-4104-002ApprovedF. Hoffmann-La Roche Ltd, Gilead Sciences IncTamiflu, Hanmi Flu, 达菲SwitzerlandInfluenza, HumanF. Hoffmann-La Roche Ltd1999-09-21Influenza A virus infections; Influenza in Birds; Influenza, Human; Kidney Failure, Chronic; Obesity; Purpura, Thrombocytopenic, Idiopathic
詳細
Peramivir HydrateBCX-1812; JNJ-2; S-021812; RWJ-270201ApprovedBiocryst Pharmaceuticals IncPeramiflu, Alpivab, 力纬, Rapiacta, Rapivab, Enpiflu PremixJapanInfluenza, Humannull2010-01-13Cough; Fatigue; Fever; Headache; Influenza A virus infections; Influenza B virus infection; Influenza, Human; Myalgia; Nasal Obstruction; Pharyngitis
詳細
  • 詳細
  • 製品リスト
  • 市販薬剤に関する情報
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8